Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation.

CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity. Cross-linking of CD26 and CD3 with immobilized mAbs can deliver a costimulatory signal that contributes to T cell activation. Our earlier studies revealed that cross-linking of CD26 induces its internalization, the phosphorylation of a number of proteins involved in the signaling pathway, and subsequent T cell proliferation. Although these findings suggest the importance of internalization in the function of CD26, CD26 has only 6 aa residues in its cytoplasmic region with no known motif for endocytosis. In the present study, we have identified the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGFIIR) as a binding protein for CD26 and that mannose 6-phosphate (M6P) residues in the carbohydrate moiety of CD26 are critical for this binding. Activation of peripheral blood T cells results in the mannose 6 phosphorylation of CD26. In addition, the cross-linking of CD26 with an anti-CD26 antibody induces not only capping and internalization of CD26 but also colocalization of CD26 with M6P/IGFIIR. Finally, both internalization of CD26 and the T cell proliferative response induced by CD26-mediated costimulation were inhibited by the addition of M6P, but not by glucose 6-phosphate or mannose 1-phosphate. These results indicate that internalization of CD26 after cross-linking is mediated in part by M6P/IGFIIR and that the interaction between mannose 6-phosphorylated CD26 and M6P/IGFIIR may play an important role in CD26-mediated T cell costimulatory signaling.

[1]  R. Abe,et al.  Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Engagement Delivers an Inhibitory Signal through the Membrane-Proximal Region in the Absence of the Tyrosine Motif in the Cytoplasmic Tail , 1999, The Journal of experimental medicine.

[2]  B. Hoflack,et al.  Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Mediates Internalization and Degradation of Leukemia Inhibitory Factor but Not Signal Transduction* , 1999, The Journal of Biological Chemistry.

[3]  S. Iwata,et al.  CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. , 1999, International immunology.

[4]  J Bell,et al.  Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Moreau,et al.  The Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Nanomolar Affinity Receptor for Glycosylated Human Leukemia Inhibitory Factor* , 1998, The Journal of Biological Chemistry.

[6]  T. Saito Negative regulation of T cell activation. , 1998, Current opinion in immunology.

[7]  H. Vorum,et al.  Mannose 6-Phosphate/Insulin-like Growth Factor–II Receptor Targets the Urokinase Receptor to Lysosomes via a Novel Binding Interaction , 1998, The Journal of cell biology.

[8]  Dominique Schols,et al.  Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV , 1998, The Journal of Biological Chemistry.

[9]  Chika Morimoto,et al.  The structure and function of CD26 in the T‐cell immune response , 1998, Immunological reviews.

[10]  M. Hegen,et al.  Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. , 1997, Journal of immunology.

[11]  A. Leaf,et al.  Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Ditto,et al.  Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage , 1997, The Journal of experimental medicine.

[13]  Yuan Zhang,et al.  Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. V. Vander Heiden,et al.  Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. , 1997, Journal of immunology.

[15]  J. Bonifacino,et al.  Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. , 1997, Immunity.

[16]  K. Bennett,et al.  Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. , 1996, Immunity.

[17]  M. Hegen,et al.  Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. , 1996, Journal of immunology.

[18]  M. Reth,et al.  The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin‐related protein. , 1994, The EMBO journal.

[19]  C. Morimoto,et al.  Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Morimoto,et al.  Direct association of adenosine deaminase with a T cell activation antigen, CD26. , 1993, Science.

[21]  S. Vijayasaradhi,et al.  A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase , 1993, The Journal of experimental medicine.

[22]  T. Tanaka Cloning and functional expression of the T cell activation antigen CD26. , 1993, Journal of immunology.

[23]  C. Morimoto,et al.  Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. , 1992, Molecular immunology.

[24]  C. Morimoto,et al.  Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. , 1991, Journal of immunology.

[25]  D. Rifkin,et al.  Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Morimoto,et al.  Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. , 1990, Journal of immunology.

[27]  C. Morimoto,et al.  Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. , 1990, Journal of immunology.

[28]  M. Hegen,et al.  The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. , 1990, Journal of immunology.

[29]  N. Letvin,et al.  1F7, a novel cell surface molecule, involved in helper function of CD4 cells. , 1989, Journal of Immunology.

[30]  K. Migita,et al.  Increment of Tal positive cells in peripheral blood from patients with rheumatoid arthritis. , 1989, The Journal of rheumatology.

[31]  A. Brunner,et al.  Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. , 1988, The Journal of biological chemistry.

[32]  D. Nathans,et al.  Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. , 1988, The Journal of biological chemistry.

[33]  R. Klausner,et al.  Molecular cloning of the zeta chain of the T cell antigen receptor. , 1988, Science.

[34]  W. Sly,et al.  The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in COS cells. , 1988, The Journal of biological chemistry.

[35]  W. Rutter,et al.  Insulin-like growth factor II receptor as a multifunctional binding protein , 1987, Nature.

[36]  Rochelle Hirschhorn Adenosine deaminase deficiency. , 1987, Hospital practice.

[37]  E. Reinherz,et al.  In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. , 1985, The New England journal of medicine.

[38]  M. Hegen,et al.  Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function. , 1998, Molecular immunology.

[39]  R. Hirschhorn Overview of Biochemical Abnormalities and Molecular Genetics of Adenosine Deaminase Deficiency , 1993, Pediatric Research.

[40]  S. Kornfeld Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. , 1992, Annual review of biochemistry.